Saladaz Biomedical has named Edward Erickson as its new president and CEO. Prior to joining Saladax, Erickson was president and CEO of BioNanomatrix. Before that, he was chairman, president, and CEO of Cellatope. He held similar roles at Immunicon, DepoTech, and Cholestech.
Erickson is currently a director of BioNanomatrix, Metabolon, and MDxHealth. He holds an MBA from the Harvard Graduate School of Business Administration and BS and MS degrees from the Illinois Institute of Technology.
Sequenom has appointed William Welch to be senior vice president of diagnostics, a role in which he will be responsible for all commercial aspects of the firm’s diagnostics business. Welch formerly was senior VP and chief commercial officer at Monogram Biosciences, VP of sales and marketing at La Jolla Pharmaceuticals, and he worked in general management at Abbott Laboratories.
Agilent Technologies has named Tachi Yamada to its board of directors. Yamada currently serves as president of the global health program of the Bill & Melinda Gates Foundation. Previously, he was chairman of research and development at GlaxoSmithKline.